Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
Bloomfield
Daniel M
DM
Data Coordinating Center, The MTWA in CHF Study, PH 9-103D, Department of Medicine, Columbia University, 630 W 168th St, New York, NY 10032, USA. dmb9@columbia.edu.
Steinman
Richard C
RC
Namerow
Pearila B
PB
Parides
Michael
M
Davidenko
Jorge
J
Kaufman
Elizabeth S
ES
Shinn
Timothy
T
Curtis
Anne
A
Fontaine
John
J
Holmes
Douglas
D
Russo
Andrea
A
Tang
Chuen
C
Bigger
J Thomas
JT
D000368:Aged; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000401:mortality / Q000517:prevention & control / Q000601:surgery; D002317:Cardiovascular Agents / Q000627:therapeutic use; D019090:Case Management; D003131:Combined Modality Therapy; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004554:Electric Countershock; D004562:Electrocardiography; D005188:False Negative Reactions; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D015993:Life Tables; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D011379:Prognosis; D011446:Prospective Studies; D012306:Risk; D016019:Survival Analysis; D016896:Treatment Outcome; D014481:United States; D018487:Ventricular Dysfunction, Left / Q000150:complications* / Q000188:drug therapy / Q000401:mortality
D002317:Cardiovascular Agents